Form D · Pharmaceuticals

CARDIOXYL PHARMACEUTICALS INC

Chapel Hill, NC · CIK 0001382014

Offering snapshot reported Nov 7, 2012 · SEC filing

Reported sold
$28.1M
Offering amount: $28.1M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 24, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 7, 2012Initial$28,050,000No comparison5SEC filing
Jul 30, 2010Initial$15,000,000No comparison2SEC filing
Aug 20, 2009Initial$9,000,000No comparison2SEC filing
Nov 15, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-186614

Source: Form D, filed Nov 7, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Barrett Director
James Barrett Director
Jeff Clark Director
Doug Cowart Executive
Robert Garland Director
Anthony Johnson Director
Vince Kalish Executive
Christopher A. Kroeger Director, Executive
Reza Mazhari Executive
John Reardon Executive
Charles Sanders Director
Gary Stiles Director
Peter Thompson Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1450 Raleigh Road Exchange East, Suite 212
Chapel Hill, NC, 27517